Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Dividend Discount Model (DDM)
- Operating Profit Margin since 2012
- Current Ratio since 2012
- Debt to Equity since 2012
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
AbbVie Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Short-term borrowings
- Short-term borrowings remained generally low and fluctuated modestly until a significant spike occurred in March and June 2025, rising sharply to 1,593 million and 5,556 million US dollars respectively. This suggests a recent increase in short-term financial obligations or liquidity needs.
- Current portion of long-term debt and finance lease obligations
- This item showed notable volatility over the periods, with peaks especially at the end of 2020 and early 2021, reaching above 11,000 million US dollars, followed by declines in late 2022 and a moderate uptrend in late 2023 and 2024. The fluctuations indicate active debt refinancing or reclassification between current and long-term debt.
- Accounts payable and accrued liabilities
- Accounts payable and accrued liabilities displayed a general upward trend, increasing from about 12,709 million US dollars in early 2020 to over 32,000 million by late 2024. Minor fluctuations exist, but the steadily rising balance reflects growing operational liabilities or supplier credit.
- Current liabilities
- Current liabilities grew from approximately 16,471 million US dollars in Q1 2020 to a peak near 43,000 million US dollars in late 2024. Although some periods exhibit declines, the overall trend indicates increasing short-term obligations, aligning with growth in accounts payable and current portions of debt.
- Long-term debt and finance lease obligations, excluding current portion
- Long-term debt remained elevated throughout the timeline, starting near 63,284 million US dollars in early 2020, peaking over 82,000 million mid-2020, then gradually declining with some fluctuations to around 62,959 million by mid-2025. This suggests ongoing debt management, possible repayments, and refinancing activities over time.
- Deferred income taxes
- Deferred income taxes decreased from 4,785 million US dollars at mid-2020 to around 2,500 million by mid-2025, indicating a reduction in deferred tax liabilities or changes in tax planning strategies.
- Other long-term liabilities
- These liabilities fluctuated between roughly 17,900 million and 33,000 million over the period, with a general increasing trend in the latter years. The variation suggests ongoing adjustments in long-term obligations beyond debt, possibly including pension liabilities or other accruals.
- Long-term liabilities
- Long-term liabilities peaked at over 110,000 million US dollars mid-2020 and early 2021 before declining to near 87,000 million in late 2023, followed by an increase to around 98,000 million by mid-2025. The pattern points to significant debt and liability restructuring activities.
- Total liabilities
- Total liabilities rose markedly from 98,614 million US dollars in early 2020 to a peak above 137,000 million by late 2024, representing substantial growth in the company’s obligations mainly driven by increases in both current and long-term liabilities.
- Common stock and treasury stock
- Common stock issued remained constant at 18 million US dollars. Treasury stock at cost showed large negative figures, indicating significant stock repurchases peaking around -9,147 million US dollars in mid-2025, implying aggressive buyback programs reducing outstanding shares.
- Additional paid-in capital
- This account showed a steady increase, from around 15,401 million in early 2020 to about 21,987 million by mid-2025, reflecting additional capital infusion or retained premiums on stock issuances.
- Retained earnings (accumulated deficit)
- Retained earnings demonstrated a declining trend, moving from a positive balance around 5,973 million early 2020 to a significant accumulated deficit nearing -11,503 million by mid-2025. This indicates sustained net losses, dividend payments exceeding earnings, or accounting adjustments reducing accumulated profits.
- Accumulated other comprehensive loss
- The comprehensive loss balance presented variability but with a mild upward trend in losses early on, followed by some improvement after 2022, decreasing from around -3,697 million early 2020 to about -1,538 million by mid-2025, indicating changes in foreign currency translation adjustments, pension, or investment valuation impacts.
- Stockholders’ equity (deficit)
- Equity shifted from a deficit of -7,415 million US dollars early 2020 to positive territory by late 2021 and early 2022, peaking near 16,283 million, before steadily declining back into slight deficit around -183 million by mid-2025. This shows periods of both strengthening and weakening equity positions, likely driven by net losses and treasury stock activities.
- Noncontrolling interest
- Noncontrolling interest increased steadily from minimal values to mid-40 millions by mid-2025, representing incremental minority ownership stakes in consolidated subsidiaries.
- Total equity (deficit)
- Total equity followed a similar pattern to stockholders’ equity, moving from a deficit early on to positive equity, then declining towards a slight deficit by mid-2025, confirming fluctuating capital health related to earnings, liabilities, and repurchase activities.
- Total liabilities and equity (deficit)
- The sum of liabilities and equity remained relatively stable, ranging from about 91,199 million in early 2020 to around 137,182 million by mid-2025. This stability reflects balancing between growing liabilities and fluctuating equity, consistent with the company’s financing and operational activities.